Welcome

Services

Guided by evolving research, we provide a precision oncology service that is clinically guided and accessible to healthcare professionals and cancer patients across Australia. We achieve this by:

• Integrating joint familial and medical oncology molecular MDTs and consultations into existing care pathways. 
• Providing a formal structure for evidence-based peer discussion of molecular test findings, to enable shared decision making in relation to diagnosis, therapeutics, risk management, and prevention.  
• Facilitating review and follow-up of potential implications for blood relatives.
• Facilitating linkage of clinical and translational research opportunities, including clinical trials.
• Recommending pathways for further molecular testing, including germline testing, integrated with their current cancer care. 
• Facilitating peer-based support for therapy decisions related to biomarker and genetic testing.  
• Providing a precision medicine conduit for rare genetic disorders where targeted therapy may be appropriate.